COVIP study

Corona Virus disease (COVID19) in Very Elderly
Intensive care Patients (VIPs)

A multinational, multicenter study of outcomes and prognostic factors in coronavirus disease (COVID-19) in very old intensive care patients.
The coronavirus SARS-CoV-2 is currently affecting thousands of patients across many countries and there is an urgent need to investigate patient characteristics and outcome trajectories.
The VIP network which has previously (2016-2019) conducted the most extensive prospective studies (VIP1, VIP2) on elderly ICU patients, has immediately deployed this study of elderly COVID19 patients starting now.

Click to register your ICU now

You will receive an further information when you register.
See the COVIP page for information, protocol, documents, notes and ethical approval etc.

114 ICUs registered
(02-04-2020 11:58)

See the
COVIP study
information page

The COVIP study is endorsed by ESICM (European Intensive Care Society)

VIP1 and VIP2 studies

The VIP1 and VIP2 studes were international, multicenter studies of the old intensive care unit population.
The data from VIP2 is currently being analyzed and published.

The Barcelona symposium is cancelled

VIP symposium in Barcelona: June 25th-26th 2020.
"Too old for the ICU?"

Visit the conference website: elderlyicu2020.com

Endorsed by ESICM.